Šalis: Prancūzija
kalba: anglų
Šaltinis: HMA (Heads of Medicines Agencies)
acetylsalicylic acid 1000 mg/g
aniMedica GmbH
QN02BA01
Oral powder
acetylsalicylic acid
Pigs
2011-09-28
Issued: October 2011 AN: 00512/2010 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Suispirin, 1000 mg/g, oral powder for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1.0 g powder contains: ACTIVE SUBSTANCE: Acetylsalicylic acid 1000 mg 3. PHARMACEUTICAL FORM Oral powder. White to almost white powder. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Pig: Supportive treatment for reduction of pyrexia in combination with,appropriate anti- infective therapy, if necessary. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or in cases of gastrointestinal irritation and ulcers, chronic gastro-intestinal disorders, bronchospasm, liver function impairment or nephropathies. Do not use in pregnant or lactating sows. Do not use in piglets less than 4 weeks of age. 4.4 SPECIAL WARNINGS In combined treatment with tetracyclines, a treatment interval of at least one hour between the two active agents is recommended. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS It must be ensured that the animals consume sufficient water during treatment. Given that Suispirin may inhibit clotting of blood, it is recommended that elective surgery should not be performed on animals within 7 days after the end of treatment. Issued: October 2011 AN: 00512/2010 Page 2 of 6 SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Do not eat, drink or smoke whilst using this product. Contact via the skin or Perskaitykite visą dokumentą